The market was valued at $101 billion in 2013 and is expected to grow at a compound annual growth rate of 7.6 percent from 2014 to 2020.
The market includes the following segments: tumor marker tests, imaging modalities, endoscopies and biopsies. It is expected that the global market for cancer imaging diagnosis will grow at a CAGR of 8.2 percent from 2014 to 2020.
North America is the dominant regional market for cancer diagnostics with a share of approximately 40.7 percent of the overall cancer diagnostics market in terms of revenue in 2013. However, the changing regulatory scenario among the high-growth countries in the Asia Pacific is also attracting leading companies in the cancer diagnostics market, according to the report.
More articles on gastroenterology:
Cantel Medical names Jorgen Hansen president, COO
Hanover Gastroenterology expands
GI physician to know: Dr. David Rubin of University of Chicago Medicine
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
